Attilio Orazi
#148,176
Most Influential Person Now
Researcher ORCID ID = 0000-0002-1660-7013
Attilio Orazi's AcademicInfluence.com Rankings
Attilio Orazicomputer-science Degrees
Computer Science
#7595
World Rank
#7995
Historical Rank
Machine Learning
#2848
World Rank
#2883
Historical Rank
Artificial Intelligence
#3141
World Rank
#3187
Historical Rank
Database
#4644
World Rank
#4824
Historical Rank
Download Badge
Computer Science
Why Is Attilio Orazi Influential?
(Suggest an Edit or Addition)Attilio Orazi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. (2016) (6707)
- Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. (2007) (893)
- The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation (1997) (866)
- European consensus on grading bone marrow fibrosis and assessment of cellularity. (2005) (693)
- Immunohistochemical double-hit score is a strong predictor of outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone. (2012) (626)
- MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program. (2013) (606)
- Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the international working group for myelofibrosis research and treatment (2008) (456)
- The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes. (2015) (386)
- The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion (2018) (346)
- Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study (2012) (304)
- Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT). (2007) (297)
- Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study. (2012) (285)
- Hyperleukocytic Leukemias and Leukostasis: A Review of Pathophysiology, Clinical Presentation and Management (2000) (283)
- International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data. (2022) (249)
- Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. (1993) (239)
- CD30 expression defines a novel subgroup of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. (2013) (212)
- Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma. (1990) (190)
- Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. (1996) (186)
- The myelodysplastic/myeloproliferative neoplasms: myeloproliferative diseases with dysplastic features (2008) (170)
- Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms. (2014) (169)
- Therapy-related myeloid neoplasms. (2009) (163)
- A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. (1994) (160)
- Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study (2013) (153)
- An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults. (2015) (147)
- Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach (2009) (143)
- Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions (2017) (141)
- Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico‐pathological entity (1991) (137)
- Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study (2014) (133)
- MPD-RC 101 prospective study of reduced-intensity allogeneic hematopoietic stem cell transplantation in patients with myelofibrosis. (2014) (132)
- Haemophilus ducreyi elicits a cutaneous infiltrate of CD4 cells during experimental human infection. (1996) (130)
- Therapeutic leukapheresis in hyperleucocytic leukaemias: lack of correlation between degree of cytoreduction and early mortality rate (1997) (123)
- Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). (2003) (118)
- Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes (2014) (115)
- Prevalence and Clinical Implications of Epstein–Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries (2014) (115)
- Rearrangements of MYC gene facilitate risk stratification in diffuse large B-cell lymphoma patients treated with rituximab-CHOP (2014) (110)
- Histopathology in the Diagnosis and Classification of Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Myelodysplastic/Myeloproliferative Diseases (2007) (109)
- Rituximab, Bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: Safety, biomarker and pharmacokinetic analysis (2006) (103)
- Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis. (2013) (101)
- Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro (1993) (100)
- Treatment of a human breast cancer xenograft with an adenovirus vector containing an interferon gene results in rapid regression due to viral oncolysis and gene therapy. (1996) (99)
- Primary testicular diffuse large B-cell lymphoma belongs to the nongerminal center B-cell-like subgroup: a study of 18 cases (2006) (99)
- Adrenal Myelolipomas Show Nonrandom X-chromosome Inactivation in Hematopoietic Elements and Fat: Support for a Clonal Origin of Myelolipomas (2006) (93)
- Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma (2015) (90)
- Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution. (2003) (90)
- Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified (2016) (87)
- Association between Intracranial Plasmacytoma and Multiple Myeloma: Clinicopathological Outcome Study (2001) (85)
- An International MDS/MPN Working Group’s perspective and recommendations on molecular pathogenesis, diagnosis and clinical characterization of myelodysplastic/myeloproliferative neoplasms (2015) (85)
- Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis. (1997) (84)
- Acute panmyelosis with myelofibrosis: an entity distinct from acute megakaryoblastic leukemia (2005) (82)
- Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis. (2003) (81)
- Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology (2006) (79)
- Proliferation-induced decline of primitive hematopoietic progenitor cell activity is coupled with an increase in apoptosis of ex vivo expanded CD34+ cells. (1998) (79)
- Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone. (2009) (79)
- Bone marrow fibrosis in 66 patients with immune thrombocytopenia treated with thrombopoietin-receptor agonists: a single-center, long-term follow-up (2014) (78)
- Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions (2019) (78)
- Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. (1997) (77)
- Spleens of myelofibrosis patients contain malignant hematopoietic stem cells. (2012) (77)
- In vivo administration of recombinant methionyl human stem cell factor expands the number of human marrow hematopoietic stem cells. (1993) (74)
- Identification of CD34+ cells in normal and pathological bone marrow biopsies by QBEND10 monoclonal antibody. (1991) (70)
- Posttransplantation lymphoproliferative disorders in bone marrow transplant recipients are aggressive diseases with a high incidence of adverse histologic and immunobiologic features. (1997) (70)
- Ex vivo culture of Fancc-/- stem/progenitor cells predisposes cells to undergo apoptosis, and surviving stem/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy. (2005) (70)
- Clinical Implications of Phosphorylated STAT3 Expression in De Novo Diffuse Large B-cell Lymphoma (2014) (69)
- Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries (2015) (68)
- The immune response to Haemophilus ducreyi resembles a delayed-type hypersensitivity reaction throughout experimental infection of human subjects. (1998) (68)
- Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. (1993) (67)
- Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors (1993) (67)
- Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease (2013) (64)
- Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors (1993) (64)
- Bone marrow histopathology in myeloproliferative disorders--current diagnostic approach. (2005) (62)
- Morphologic and immunohistochemical evaluation of splenic hematopoietic proliferations in neoplastic and benign disorders (2005) (61)
- Lymphoblastic transformation of follicular lymphoma: a clinicopathologic and molecular analysis of 7 patients. (2015) (60)
- Assessment of CD37 B-cell antigen and cell of origin significantly improves risk prediction in diffuse large B-cell lymphoma. (2016) (59)
- Prevalence and clinical implications of cyclin D1 expression in diffuse large B‐cell lymphoma (DLBCL) treated with immunochemotherapy: A report from the International DLBCL Rituximab‐CHOP Consortium Program (2014) (58)
- Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma (2015) (58)
- Continuous in vivo infusion of interferon-gamma (IFN-gamma) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in Fancc-/- mice. (2004) (56)
- THE UPDATED WHO CLASSIFICATION OF HEMATOLOGICAL MALIGNANCIES The 2016 revision to the World Health Organization classi fi cation of myeloid neoplasms and acute leukemia (2016) (56)
- Recombinant human interleukin-3 and recombinant human granulocyte-macrophage colony-stimulating factor administered in vivo after high-dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow. (1992) (56)
- Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia. (2010) (53)
- CD34 immunohistochemistry of bone marrow biopsies: Prognostic significance in primary myelodysplastic syndromes (1994) (53)
- Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study (2014) (53)
- The bone marrow stroma in hematological neoplasms—a guilty bystander (2011) (52)
- In vivo interleukin 2-induced activation of lymphokine-activated killer cells and tumor cytotoxic T-cells in cervical lymph nodes of patients with head and neck tumors. (1990) (52)
- Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: Data from the EXTEND study (2015) (51)
- Rosai–Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation (2016) (50)
- Myeloid progenitor cell proliferation and mobilization effects of BB10010, a genetically engineered variant of human macrophage inflammatory protein-1alpha, in a phase I clinical trial in patients with relapsed/refractory breast cancer. (1998) (50)
- Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion. (2012) (50)
- Prolonged administration of granulocyte colony-stimulating factor (filgrastim) to patients with Fanconi anemia: a pilot study. (1996) (49)
- Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP (2015) (49)
- Standards and Impact of Hematopathology in Myelodysplastic Syndromes (MDS) (2010) (48)
- Tumor proliferative activity is predictive of pathological stage in clinical stage A nonseminomatous testicular germ cell tumors. (1996) (47)
- Effects of recombinant human interleukin-11 (Neumega rhIL-11 growth factor) on megakaryocytopoiesis in human bone marrow. (1996) (46)
- Idiopathic hypocomplementemic interstitial nephritis with extensive tubulointerstitial deposits. (2001) (46)
- Recombinant interferon-α in myelofibrosis reduces bone marrow fibrosis, improves its morphology and is associated with clinical response (2015) (46)
- Functional p85α gene is required for normal murine fetal erythropoiesis (2003) (45)
- Comparison of interleukin-11 and epidermal growth factor on residual small intestine after massive small bowel resection. (1998) (45)
- Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome (2017) (45)
- 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity. (1997) (45)
- Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm. (2008) (45)
- Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma (2016) (44)
- Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia (2017) (44)
- Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma (2016) (43)
- Evidence against KSHV infection in the pathogenesis of multiple myeloma. (1998) (42)
- Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometry. (2000) (42)
- Transformation of follicular lymphoma to plasmablastic lymphoma with c-myc gene rearrangement. (2010) (41)
- Assessment of cell proliferation in paraffin sections of normal bone marrow by the monoclonal antibodies Ki-67 and PCNA. (1994) (41)
- Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma (2015) (40)
- Age cutoff for Epstein-Barr virus-positive diffuse large B-cell lymphoma–is it necessary? (2015) (40)
- Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program. (2013) (39)
- The importance of angiogenesis markers in the outcome of patients with diffuse large B cell lymphoma: a retrospective study of 97 patients (2008) (39)
- Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia (2013) (38)
- Clinical Significance of PTEN Deletion, Mutation, and Loss of PTEN Expression in De Novo Diffuse Large B-Cell Lymphoma (2018) (38)
- Thrombopoietin receptor agonist therapy in primary immune thrombocytopenia is associated with bone marrow hypercellularity and mild reticulin fibrosis but not other stromal abnormalities (2012) (38)
- Therapy-related myelodysplastic syndromes: FAB classification, bone marrow histology, and immunohistology in the prognostic assessment. (1993) (37)
- The effect of initial molecular profile on response to recombinant interferon‐α (rIFNα) treatment in early myelofibrosis (2017) (37)
- Autologous hematopoietic stem-cell transplantation in combination with thalidomide as treatment for histiocytic sarcoma: a case report and review of the literature. (2011) (36)
- Hematopoietic neoplasms with 9p24/JAK2 rearrangement: a multicenter study (2018) (36)
- Fibroproliferative activity in patients with immune thrombocytopenia (ITP) treated with thrombopoietic agents (2011) (35)
- The correlation of P53 protein expression with proliferative activity and occult metastases in clinical stage I non-seminomatous germ cell tumors of the testis. (1994) (35)
- Phenotypic and functional analysis of lymphocytes infiltrating paediatric tumours, with a characterization of the tumour phenotype (2005) (35)
- Leukemic meningitis complicating early stage chronic lymphocytic leukemia. (1997) (35)
- K-Ras is essential for normal fetal liver erythropoiesis. (2005) (34)
- CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia. (1994) (34)
- Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage a nonseminomatous testicular germ cell tumor at low risk for occult metastasis (1995) (34)
- Terminal deoxynucleotidyl transferase staining of malignant lymphomas in paraffin sections. (1994) (33)
- European LeukemiaNet study on the reproducibility of bone marrow features in masked polycythemia vera and differentiation from essential thrombocythemia (2017) (33)
- Flow cytometric immunophenotypic characterization of pediatric and adult minimally differentiated acute myeloid leukemia (AML-M0). (2000) (33)
- Myeloproliferative neoplasms with concurrent BCR–ABL1 translocation and JAK2 V617F mutation: a multi-institutional study from the bone marrow pathology group (2018) (33)
- Mastocytosis and related disorders. (2012) (33)
- Flow cytometric analysis of normal and reactive spleen (2004) (33)
- Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors. (1995) (32)
- A 2-Year, Longitudinal, Prospective Study of the Effects of Eltrombopag on Bone Marrow in Patients with Chronic Immune Thrombocytopenia (2016) (32)
- Terminal deoxynucleotidyl transferase staining in acute leukemia and normal bone marrow in routinely processed paraffin sections. (1994) (30)
- Primary testicular and paratesticular lymphoma: a retrospective clinicopathologic study of 34 cases with emphasis on differential diagnosis. (2007) (30)
- Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow (2017) (30)
- Chronic lymphocytic leukemia/small lymphocytic lymphoma with trisomy 12 and focal cyclin d1 expression: a potential diagnostic pitfall. (2009) (30)
- Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen expression in Hodgkin's disease. (1995) (29)
- Frequent p53 overexpression in therapy related myelodysplastic syndromes and acute myeloid leukemias: an immunohistochemical study of bone marrow biopsies. (1993) (29)
- Functional p85alpha gene is required for normal murine fetal erythropoiesis. (2003) (29)
- Bone marrow fibrosis and diagnosis of essential thrombocythemia. (2009) (28)
- A case of chronic neutrophilic leukemia with trisomy 8. (1989) (27)
- IgG4 plasma cell myeloma: new insights into the pathogenesis of IgG4-related disease (2014) (27)
- Morphologic and cytogenetic differences between post-polycythemic myelofibrosis and primary myelofibrosis in fibrotic stage (2013) (26)
- Thrombotic Thrombocytopenic Purpura: Yesterday, Today, Tomorrow (2004) (26)
- Impact of the 2016 revised WHO criteria for myeloproliferative neoplasms, unclassifiable: Comparison with the 2008 version (2017) (25)
- De novo acute myeloid leukemia with 20–29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study (2014) (25)
- Phase I dose escalation study of lestaurtinib in patients with myelofibrosis (2015) (24)
- Visceral leishmaniasis in a rheumatoid arthritis patient treated with methotrexate. (2009) (24)
- Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016 (2018) (24)
- Addition of rituximab to chemotherapy overcomes the negative prognostic impact of cyclin E expression in diffuse large B-cell lymphoma (2013) (23)
- Prognostic and biological significance of survivin expression in patients with diffuse large B-cell lymphoma treated with rituximab-CHOP therapy (2015) (23)
- Selective purging by human interleukin‐2 activated lymphocytes of bone marrows contaminated with a lymphoma line or autologous leukaemic cells (1991) (23)
- Splenic extramedullary hematopoietic proliferation in Philadelphia chromosome-negative myeloproliferative neoplasms: heterogeneous morphology and cytological composition (2012) (23)
- The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia. (2014) (23)
- p53 overexpression in myeloid leukemic disorders is associated with increased apoptosis of hematopoietic marrow cells and ineffective hematopoiesis. (1996) (23)
- Illustrated pathology of the bone marrow (2006) (23)
- Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma (2014) (21)
- Neutrophilic leukocytosis in advanced stage polycythemia vera: hematopathologic features and prognostic implications (2015) (21)
- The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations (2017) (21)
- Intraocular inflammatory myofibroblastic tumor with ALK overexpression. (2004) (21)
- JAK2 V617F‐positive acute myeloid leukaemia (AML): a comparison between de novo AML and secondary AML transformed from an underlying myeloproliferative neoplasm. A study from the Bone Marrow Pathology Group (2018) (21)
- Comparison of therapy‐related and de novo core binding factor acute myeloid leukemia: A bone marrow pathology group study (2020) (20)
- RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma (2016) (20)
- Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining (2004) (20)
- Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma. (2014) (20)
- European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360–5 - Comment (2012) (19)
- Composite chronic lymphocytic leukemia/small lymphocytic lymphoma and follicular lymphoma are biclonal lymphomas: a report of two cases. (2012) (19)
- Evaluation of NF-κB subunit expression and signaling pathway activation demonstrates that p52 expression confers better outcome in germinal center B-cell-like diffuse large B-cell lymphoma in association with CD30 and BCL2 functions (2015) (19)
- A cystic partially differentiated nephroblastoma producing α-fetoprotein (1992) (19)
- Primary hepatic B-cell lymphoma in a child. (1993) (19)
- p63 expression confers significantly better survival outcomes in high-risk diffuse large B-cell lymphoma and demonstrates p53-like and p53-independent tumor suppressor function (2016) (19)
- Analysis of loss of heterozygosity and X chromosome inactivation in spleens with myeloproliferative disorders and acute myeloid leukemia (2005) (19)
- Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative Neoplasms. (2015) (19)
- Benign hematologic neoplasm associated with mediastinal mature teratoma in a patient with Klinefelter's syndrome: a case report. (1994) (17)
- Update on the pathologic diagnosis of chronic myelomonocytic leukemia (2019) (17)
- Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes. (1994) (17)
- Inflammatory pseudotumor of the spleen in a 6-year-old child: a clinicopathologic study. (2009) (17)
- Myeloproliferative neoplasms (BCR‐ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnostic principles and upcoming updates (2016) (17)
- Preliminary Studies on Melatonin in the Treatment of Myelodysplastic Syndromes Following Cancer Chemotherapy (1990) (16)
- Mutational Profile and Prognostic Significance of TP53 in Diffuse Large B-cell Lymphoma Patients Treated with Rituximab-CHOP: A Report From an International DLBCL Rituximab-CHOP Consortium Program Study (2013) (16)
- Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group (2019) (16)
- Advances in myelofibrosis: a clinical case approach (2013) (16)
- Genomic Profiling for Clinical Decision Making in Myeloid Neoplasms and Acute Leukemia. (2022) (16)
- The Spectrum of Aggressive Mastocytosis: A Workshop Report and Literature Review (2019) (15)
- Myelodysplastic Syndrome, Unclassifiable (MDS-U) With 1% Blasts Is a Distinct Subgroup of MDS-U With a Poor Prognosis (2017) (15)
- Bone marrow morphology predicts additional chromosomal abnormalities in patients with myelodysplastic syndrome with del(5q). (2013) (15)
- Distinct morphophenotypic features of chronic B‐cell leukaemias identified with CDlc and CD23 antibodies (1991) (15)
- Myelodysplastic syndromes. (2009) (15)
- Splenectomy in agnogenic myeloid metaplasia. (1999) (15)
- The stromal composition of mast cell aggregates in systemic mastocytosis (2009) (15)
- Cytogenetic study in therapy-related myelodysplastic syndromes (t-MDS) and acute non-lymphocytic leukaemia (t-ANLL). (1990) (14)
- Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases. (2015) (14)
- Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases (2017) (14)
- Evaluation of stroma in human immunodeficiency virus/acquired immunodeficiency syndrome-affected bone marrows and correlation with CD4 counts. (2005) (14)
- The Effect of Initial Molecular Profile on Response to Recombinant Interferon Alpha (rIFNα) Treatment in Early Myelofibrosis (2016) (14)
- Impact of bone marrow pathology on the clinical management of Philadelphia chromosome-negative myeloproliferative neoplasms. (2015) (14)
- Diffuse blastoid B-cell lymphoma: a histologically aggressive variant of t(14;18)-negative follicular lymphoma (2009) (14)
- A multimodality work‐up of patients with Hypereosinophilia (2018) (14)
- Evaluation of Bone Marrow Reticulin in Patients with Chronic Immune Thrombocytopenic Purpura (ITP) Treated with Eltrombopag – Data From the EXTEND Study (2011) (13)
- Leptomeningeal relapse of multiple myeloma following allogeneic stem cell transplantation. (2002) (13)
- ”Composite” lymphoma, lymphoplasmacytoid and diffuse large B-cell lymphoma of the spleen: molecular-genetic evidence of a common clonal origin (1999) (13)
- Myeloid/Lymphoid Neoplasms Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, or FGFR1 or With PCM1-JAK2. (2020) (13)
- Concordance among hematopathologists in classifying blasts plus promonocytes: A bone marrow pathology group study (2020) (13)
- Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression (2017) (13)
- Commentary: Immunohistochemistry represents a useful tool to study human cell engraftment in SCID mice transplantation models. (1994) (12)
- Myeloid neoplasms with isolated del(5q) and JAK2 V617F mutation: a “grey zone” combination of myelodysplastic and myeloproliferative features? (2020) (12)
- Clonal X-chromosome inactivation suggests that splenic cord capillary hemangioma is a true neoplasm and not a subtype of splenic hamartoma (2011) (12)
- Reactive Eosinophil Proliferations in Tissue and the Lymphocytic Variant of Hypereosinophilic Syndrome. (2020) (12)
- Myeloid neoplasms with features intermediate between primary myelofibrosis and chronic myelomonocytic leukemia (2018) (12)
- Classification of myeloid neoplasms/acute leukemia: Global perspectives and the international consensus classification approach (2022) (12)
- Retroviral vector integration in post-transplant hematopoiesis in mice conditioned with either submyeloablative or ablative irradiation (2009) (12)
- Molecular Epidemiology of EBNA-1 Substrains of Epstein-Barr Virus in Posttransplant Lymphoproliferative Disorders Which Have Infrequent p53 Mutations (2000) (12)
- The genetics of interdigitating dendritic cell sarcoma share some changes with Langerhans cell histiocytosis in select cases. (2014) (11)
- A cystic partially differentiated nephroblastoma producing alpha-fetoprotein. (1992) (10)
- Knowles Neoplastic Hematopathology (2013) (10)
- Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F‐positive myeloproliferative neoplasms (2019) (10)
- Ethnic and border differences on blood cancer presentation and outcomes: A Texas population‐based study (2020) (10)
- Inactivation of BANK1 in a novel IGH-associated translocation t(4;14)(q24;q32) suggests a tumor suppressor role in B-cell lymphoma (2014) (9)
- Myeloid/lymphoid neoplasms with FLT3 rearrangement (2021) (9)
- Recombinant Interferon Alpha (rIFN) May Retard Progression Of Early Myelofibrosis By Reducing Splenomegaly and By Decreasing Marrow Fibrosis (2013) (9)
- Primary mediastinal germ cell tumor evolving into an extramedullary acute megakaryoblastic leukemia causing cord compression. (2008) (9)
- Acute leukemia with the (4;11) chromosome translocation following treatment for Hodgkin's disease: a case study. (1988) (9)
- Mediastinal non-seminomatous germ cell tumours: their association with non-germ cell malignancies. (1999) (9)
- Increased susceptibility to lymphokine activated killer (LAK) lysis of relapsing vs. newly diagnosed acute leukemic cells without changes in drug resistance or in the expression of adhesion molecules. (1992) (9)
- Acute monoblastic leukemia as a second malignancy following chemotherapy for osteogenic sarcoma: a case report. (1988) (9)
- World Health Organization classification of myelodysplastic syndromes. (2012) (9)
- A Longitudinal Prospective Study Evaluating the Effects of Eltrombopag Treatment On Bone Marrow in Patients with Chronic Immune Thrombocytopenia: Interim Analysis At 1 Year. (2012) (9)
- Nuclear factor-erythroid 2, nerve growth factor receptor, and CD34-microvessel density are differentially expressed in primary myelofibrosis, polycythemia vera, and essential thrombocythemia. (2015) (9)
- Electron Microscopy in an Oncologic Institution. Diagnostic Usefulness in Surgical Pathology (1988) (8)
- Chronic myeloid neoplasms harboring concomitant mutations in myeloproliferative neoplasm driver genes (JAK2/MPL/CALR) and SF3B1 (2020) (8)
- How I investigate chronic myelomonocytic leukemia (2019) (8)
- Pure Erythroid Leukemia Mimicking Ewing Sarcoma/Primitive Neuroectodermal Tumor in an Infant (2016) (8)
- Clinicopathologic evaluation of cytopenic patients with isolated trisomy 8: a detailed comparison between idiopathic cytopenia of unknown significance and low-grade myelodysplastic syndrome (2017) (8)
- The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms (2022) (7)
- Most Myeloid Neoplasms With Deletion of Chromosome 16q Are Distinct From Acute Myeloid Leukemia With Inv(16)(p13.1q22): A Bone Marrow Pathology Group Multicenter Study (2017) (7)
- Nephroblastoma with Neuroendocrine Differentiation (1989) (7)
- Myeloid sarcoma with t(11;19)(q23;p13.3) (MLL‐ELL) in the uterine cervix (2011) (7)
- Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression (2020) (7)
- In vivo effects of recombinant human stem cell factor treatment. A morphologic and immunohistochemical study of bone marrow biopsies. (1995) (7)
- The technicon H6000 automated hematology analyzer in the diagnosis and classification of the myelodysplastic syndromes. (1990) (7)
- The effects of hematopoietic stem cell transplant on splenic extramedullary hematopoiesis in patients with myeloproliferative neoplasm-associated myelofibrosis. (2016) (6)
- Proliferating normal bone marrow cells do stain for Ki‐67 antigen (1993) (6)
- Terminal deoxynucleotidyl transferase-positive cells in spleen, appendix and branchial cleft cysts in pediatric patients. (2006) (6)
- Bone Marrow Fibrosis In Immune Thrombocytopenia (ITP) Patients Treated With Thrombopoietin Receptor Agonists (TRA) – a Single Center Long-Term Follow-Up (2013) (6)
- Trends in Bone Marrow Sampling and Core Biopsy Specimen Adequacy in the United States and Canada: A Multicenter Study (2018) (6)
- Eosinophilia/Hypereosinophilia in the Setting of Reactive and Idiopathic Causes, Well-Defined Myeloid or Lymphoid Leukemias, or Germline Disorders. (2020) (6)
- Morphologic, Immunologic, and Cytogenetic Characteristics of Secondary Acute Unclassifiable Leukemia in Hodgkin's Disease (1988) (6)
- MYC/BCL2 Protein Co-Expression Defines a Unique Subset of Aggressive Lymphoma and Contributes to the Inferior Prognosis of Activated B-cell Subtype of Diffuse Large B-cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program Study (2013) (5)
- mdm-2 oncoprotein expression associated with deletion of the long arm of chromosome 12 in a case of mantle cell lymphoma with blastoid transformation [corrected]. (1996) (5)
- The International Consensus Classification of acute myeloid leukemia (2022) (5)
- Chronic lymphocytic leukemia with TP53 gene alterations: a detailed clinicopathologic analysis (2019) (5)
- Updates on eosinophilic disorders (2022) (5)
- Myelodysplastic syndromes. (2011) (5)
- Advances in myelodysplastic/myeloproliferative neoplasms (2022) (5)
- Assessment of CD 37 B-cell antigen and cell-of-origin significantly improves risk prediction in diffuse large B-cell lymphoma (2016) (5)
- Evaluation of bone marrow morphology is essential for assessing disease status in recombinant interferon α-treated polycythemia vera patients (2017) (5)
- The Italian registry of soft tissue tumors. (1988) (5)
- Pro-vs-anti-CD45. (1996) (4)
- Loss of heterozygosity identifies genetic changes in chronic myeloid disorders, including myeloproliferative disorders, myelodysplastic syndromes and chronic myelomonocytic leukemia (2007) (4)
- A reevaluation of erythroid predominance in Acute Myeloid Leukemia using the updated WHO 2016 Criteria (2018) (4)
- Acute aleukemic mast cell leukemia: Report of a case and review of the literature (2020) (4)
- The t(14;18)(q32;q21) Characterizes a Subset of Patients with Diffuse Large-B Cell Lymphoma of Germinal Center Origin with Poor Outcome: Report From the International DLBCL Rituximab-CHOP Consortium Program Study (2011) (4)
- The international consensus classification of mastocytosis and related entities (2022) (4)
- Myelodysplastic/ Myeloproliferative Neoplasms-Unclassifiable (MDS/MPN-U) with Isolated Isochromosome 17q Represents a Distinct Clinico-Biologic Subset: A Multi-institutional Collaborative Study from the Bone Marrow Pathology Group (2021) (4)
- CD34 immunoperoxidase staining for the diagnosis of myelodysplastic syndromes and chronic myeloid leukaemia. (1995) (4)
- Prospective Evaluation of the World Health Organization Criteria for the Diagnosis of Polycythemia Vera (2011) (4)
- CD4-Negative Variant of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm With a Novel PBRM1 Mutation in an 11-Year-Old Girl. (2017) (3)
- Clinical, immunophenotypic and genomic findings of NK lymphoblastic leukemia: a study from the Bone Marrow Pathology Group (2021) (3)
- Cyclin D 1 – Positive Diffuse Large B-Cell Lymphoma With IGH-CCND 1 Translocation and BCL 6 Rearrangement A Report of Two Cases (2015) (3)
- Mixed-lineage leukemias and phenotypic shifts occurring in relapsed cases of acute T lymphoblastic lymphomas. (1988) (3)
- The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations (2017) (3)
- MYC mutation profiling and prognostic significance in de novo diffuse large B-cell lymphoma (2016) (3)
- A lucky mistake: the splenic glands of Marcello Malpighi. (2017) (3)
- International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms (2022) (3)
- Radiation Therapy Significantly Improves Survival Of Patients With Diffuse Large B-Cell Lymphoma Associated With MYC Translocation: A Report From The International DLBCL Rituximab-CHOP Consortium Program (2013) (3)
- The International Consensus Classification of myelodysplastic syndromes and related entities (2022) (3)
- Pure (acute) erythroid leukemia: morphology, immunophenotype, cytogenetics, mutations, treatment details, and survival data among 41 Mayo Clinic cases (2022) (3)
- Response to “The WHO classification of haematolymphoid tumours” (Editorial) (2022) (3)
- Characterization of Splenic CD34+ Cells From Patients with Primary Myelofibrosis (2011) (3)
- Session 8: pathology and clinicopathological correlations 077 THE RELIABILITY OF IMMUNOHISTOCHEMICAL ANALYSIS OF TUMOR MICROENVIRONMENT IN FOLLICULAR LYMPHOMA; A VALIDATION STUDY FROM THE LUNENBURG LYMPHOMA BIOMARKER CONSORTIUM (LLBC) (2011) (2)
- Quantification of marrow CD34+ cells: an important tool for distinguishing between hypoplastic myelodysplastic syndromes and aplastic anemia (2006) (2)
- Evaluation Of The Effects Of Long-Term Treatment With Eltrombopag On Bone Marrow In Patients With Chronic Immune Thrombocytopenia (ITP) — Data From The EXTEND Study (2013) (2)
- Correspondence re: Kaiserling E, Horny HP, Geerts M-L, Schmid U: Skin involvement in myelogenous leukemia: morphologic and immunophenotypic heterogeneity of skin infiltrates. Mod Pathol 7:771, 1994. (1995) (2)
- STAT3 Expression and Clinical Implications In De Novo Diffuse Large B-Cell Lymphoma: A Report From The International DLBCL Rituximab-CHOP Consortium Program (2013) (2)
- Acute leukemia with t(8;21) can express T-lineage-associated markers. (1992) (2)
- EAHP 2020 workshop proceedings, pediatric myeloid neoplasms (2022) (2)
- Classification of rare pediatric myeloid neoplasia—Quo vadis? (2022) (2)
- Issues in diagnosis of small B cell lymphoid neoplasms involving the bone marrow and peripheral blood. Report on the Bone Marrow Workshop of the XVIIth meeting of the European Association for Haematopathology and the Society for Hematopathology (2016) (2)
- Comments on pre‐fibrotic myelofibrosis and how should it be managed (2019) (2)
- NF-κB Subunit c-Rel Cooperates with Myc and Mutated p53 to Confer Significantly Worse Survival in Patients with Diffuse Large B-Cell Lymphoma: A Report from the International DLBCL Rituximab-CHOP Consortium Program (2014) (2)
- Mastocytosis. (2019) (2)
- Clinical, Immunophenotypic and Genomic Findings of Acute Undifferentiated Leukemia and Comparison to AML with Minimal Differentiation: A Study from the Bone Marrow Pathology Group (2018) (2)
- Detection of bone marrow minimal disease in non-Hodgkin's lymphoma patients by gene rearrangement analysis. (1989) (2)
- Inactivation Of BANK1 By a Novel IGH -Associated Translocation and 5’ Hypermethylation In B-Cell Lymphomas (2013) (2)
- A 51-year-old female with nephrotic syndrome, renal failure, and hepatitis c virus infection. (2001) (2)
- Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group (2018) (2)
- B-cell neoplasms and Hodgkin lymphoma in the spleen. (2020) (2)
- Clinicopathologic and Molecular Analysis of Normal Karyotype Therapy-Related and De Novo Acute Myeloid Leukemia: A Multi-Institutional Study by the Bone Marrow Pathology Group. (2023) (1)
- Of drills and bones: Giovanni Ghedini and the origin of bone marrow biopsy (2022) (1)
- Rituximab-CHOP Consortium Program demonstrates high-risk gene expression signatures : a report from The activated B-cell subtype of diffuse large B-cell lymphoma and MYC / BCL 2 protein coexpression contributes to the inferior survival of (2013) (1)
- International DLBCL Rituximab-CHOP Consortium Program demonstrates high-risk gene expression signatures: a report from The activated B-cell subtype of diffuse large B-cell lymphoma and MYC/BCL2 protein coexpression contributes to the inferior survival of (2013) (1)
- Illustrated Pathology of the Bone Marrow: Myelodysplastic syndromes (2006) (1)
- Platelet Depletion During Pediatric Peripheral Blood Progenitor Cell (PBPC) Harvesting (1998) (1)
- EXAMINATION OF KSHV INFECTION IN MULTIPLE MYELOMA PATIENTS (1998) (1)
- Eltrombopag (EPAG) Treatment Improved Platelet Counts in Patients with Persistent or Chronic Immune Thrombocytopenia during a 2-Year, Phase IV, Open-Label Study (2017) (1)
- Reply to Matsui et al. (2006) (1)
- Myelodysplastic/myeloproliferative neoplasms: are morphology and immunophenotyping still relevant? (2020) (1)
- Results from the Myeloproliferative Neoplasm Patient Care Survey: Patient Care Opportunities and Challenges (2018) (1)
- Erratum: Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries (2015) (1)
- Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment (2019) (1)
- Clinical Impact of TP53 Gene Mutations in Diffuse Large B-Cell Lymphoma (DLBCL): An International DLBCL Rituxan-CHOP Consortium Program Study. (2009) (1)
- Akt activation confers an inferior survival in patients with activated B-cell subtype of diffuse large B-cell lymphoma: a report from The International DLBCL Rituximab-CHOP Consortium Program (2014) (1)
- Bone Marrow Core Biopsy Adequacy and Variability in the United Stated and Canada: A Multicenter Retrospective Study (2014) (1)
- Erratum to Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in Western countries [Oncotarget, 8, (2015), 5615-5633] (2015) (1)
- Proteomic profiling of cerebrospinal fluid to detect potential biomarkers for multiple sclerosis (2008) (1)
- Mast cell sarcoma: 2 Mayo Clinic cases (2022) (1)
- Illustrated Pathology of the Bone Marrow: Introduction (2006) (1)
- Update on the classification of myeloid neoplasms: The 2016 revised World Health Organization classification of hematopoietic and lymphoid neoplasms (2020) (1)
- Prognostic Significance and Phenotypic Manifestations of MYC/BCL2 Protein Expression in Diffuse Large B-Cell Lymphoma (DLBCL) with Extranodal Organ Involvement: A Report of the International DLBCL Rituximab-CHOP Consortium Program Study (2012) (1)
- Clinicopathologic Characterization of Acute Myeloid Leukemia and Myelodysplastic Syndrome with Inv(3)(q21q26.2)/t(3;3)(q21;q26.2) Reveals That Complex Karyotype but Not Blast Percentage Is Associated with Poor Survival; A Bone Marrow Pathology Group Study (2012) (1)
- How I Diagnose Primary Myelofibrosis. (2022) (1)
- GATA1 downregulation in prefibrotic and fibrotic stages of primary myelofibrosis and in the myelofibrotic progression of other myeloproliferative neoplasms. (2020) (1)
- Illustrated Pathology of the Bone Marrow: The normal bone marrow and an approach to bone marrow evaluation of neoplastic and proliferative processes (2006) (1)
- Primary pancreatic diffuse large B‐cell lymphoma, activated B‐cell subtype, diagnosed by endoscopic ultrasound‐guided fine needle aspiration—A case report and review of the literature (2020) (1)
- Diagnostic Bone Marrow Haematopathology (2020) (1)
- The technicon H6000 analyzer discriminates chronic lymphocytic leukemia from other B-cell leukemias through automatic assessment of large unstained cells. (1990) (1)
- Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group. (2023) (1)
- Illustrated Pathology of the Bone Marrow: Granulomatous and histiocytic disorders (2006) (0)
- Myelodysplastic Syndromes (MDS) (2019) (0)
- Reappraisal of Mast Cell Leukemia Based on a Single Institution Review of 16 Cases: Role of Mast Cell Morphology in Determining Clinical Outcome (2022) (0)
- Overexpression of NF-E2 In Vivo Causes Thrombocytosis and Acute Leukemia: A Murine Model of Myeloproliferative Neoplasms. (2009) (0)
- University of Southern Denmark Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma Ye, (2016) (0)
- Continuous in vivo infusion of interferon-gamma (IFN- (cid:1) ) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in Fancc (cid:2) / (cid:2) mice (2004) (0)
- Illustrated Pathology of the Bone Marrow: The hyperplasias (2006) (0)
- TP53 mutations and variant allele frequency in myelodysplastic syndromes with del(5q): A Mayo‐Moffitt study of 156 informative cases (2023) (0)
- decreases the risk of clonal evolution hematopoietic stem cells and - / - repopulating ability of Fancc Retroviral-mediated expression of recombinant Fancc enhances the (2013) (0)
- Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN) (2019) (0)
- Are nucleated red cells significant in patients with thrombotic thrombocytopenic purpura? (2000) (0)
- Franco Rilke (1929–2009) (2009) (0)
- The effect of in vivo administration of recombinant methionyl human stem cell factor on the number of human marrow hematopoietic stem cells. (1993) (0)
- expert panel primary myelofibrosis: recommendations from an ad hoc international diagnostic criteria for polycythemia vera, essential thrombocythemia, and Proposals and rationale for revision of the World Health Organization (2013) (0)
- Syddansk Universitet Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma (2018) (0)
- Abstract 4343: Retrospective study of incidence and survival for patients with hematological malignancies residing at the U.S./Mexico border (2020) (0)
- Protein Profiling in Childhood Precursor B Acute Lymphoblastic Leukemia using Surface Enhanced Laser Desorption/Ionization (SELDI) Mass Spectrometry: A Study of Archival Samples. (2004) (0)
- The international consensus classification of myeloid neoplasms and acute leukemias: Myeloproliferative neoplasms (2023) (0)
- Bone Marrow ExaminationDecision Making and Problem Solving (2005) (0)
- Myeloproliferative Neoplasms (2020) (0)
- Comprar Knowles Neoplastic Hematopathology, 3e | Attilio Orazi | 9781609136826 | Lippincott Williams & Wilkins (2013) (0)
- Biological determinants of long-term survival in chronic myelogenous leukemia patients treated with conventional chemotherapy. (1997) (0)
- Illustrated Pathology of the Bone Marrow: Post-therapy bone marrow changes (2006) (0)
- F.101. Acquired Hemolytic Anemia in an Infant After Small Bowel Transplantation (2008) (0)
- [Hodgkin's disease: clonality and derivation of Reed-Sternberg cells]. (1996) (0)
- Diagnostic Utility of Bone Marrow Pathology in Chronic Myeloproliferative Disorders (2007) (0)
- Diagnosis of Myelodysplastic Syndromes: Criteria and Challenges (2008) (0)
- Illustrated Pathology of the Bone Marrow: Chronic myeloproliferative disorders and systemic mastocytosis (2006) (0)
- Diffuse variant of lymphocyte-predominant Hodgkin lymphoma: a diagnostic challenge (2013) (0)
- CHAPTER 27 – Myelodysplastic/myeloproliferative neoplasms (2011) (0)
- Myelodysplastic/Myeloproliferative Neoplasms (2020) (0)
- What’s New in the Classification, Diagnosis and Therapy of Myeloid Leukemias (2023) (0)
- International Consensus Classification for myeloid neoplasms at‐a‐glance (2022) (0)
- Illustrated Pathology of the Bone Marrow: Other non-neoplastic marrow changes (2006) (0)
- Addressing the Challenges of Eosinophilia and Mastocytosis. (2020) (0)
- Triple-Negative Primary Myelofibrosis: A Bone Marrow Pathology Group Study. (2023) (0)
- Systemic mastocytosis: a (slightly) simplified diagnostic approach (2023) (0)
- 2007 Workshop of the Society for Hematopathology and European Association for Haematopathology. (2009) (0)
- Platelet loss during peripheral blood progenitor cell collections. (1996) (0)
- A Model of Clonal Evolution and Myelodysplasia (MDS) on Mice with Genetic Disruption of Both Fancc and Fancg. (2006) (0)
- Illustrated Pathology of the Bone Marrow: Myelodysplastic/myeloproliferative disorders (2006) (0)
- Antibodies and immunohistochemical evaluation for the diagnosis of hematological malignancies: an overview. (2007) (0)
- Eosinophilic myeloid neoplasms: an update (2023) (0)
- B-cell lymphoma patients treated with R-CHOP : report from an Mutational profile and prognostic significance of TP 53 in diffuse large (2012) (0)
- LYMPHOID NEOPLASIA Assessment of CD37 B-cell antigen and cell of origin signi fi cantly improves risk prediction in diffuse large B-cell lymphoma (2016) (0)
- Post-operative hyperleukocytosis and leukostasis as the initial presentation of chronic myelomonocytic leukemia: A case report and review of literature. (2021) (0)
- Bone Marrow Histology and Red Cell Mass Allow Accurate Identification of Early Stage Polycythemia Vera (2012) (0)
- Progression, transformation, and unusual manifestations of myelodysplastic syndromes and myelodysplastic-myeloproliferative neoplasms: lessons learned from the XIV European Bone Marrow Working Group Course 2019 (2020) (0)
- Histological Diagnosis of Tumours by Pattern Analysis: An A-Z Guide (1998) (0)
- Plenary Paper (2013) (0)
- Prognostic Significance of Survivin Expression in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP Therapy: A Report from the International DLBCL Rituximab-CHOP Consortium Program (2015) (0)
- Prevalence and Clinical Implications of Epstein-Barr Virus Infection in de novo Diffuse Large B-Cell Lymphoma in Western Countries: A report from The International DLBCL Rituximab-CHOP Consortium Program (2014) (0)
- Correction to: Myelodysplastic/myeloproliferative neoplasms-unclassifiable with isolated isochromosome 17q represents a distinct clinico-biologic subset: a multi-institutional collaborative study from the Bone Marrow Pathology Group (2021) (0)
- Illustrated Pathology of the Bone Marrow: Chronic lymphoproliferative disorders and malignant lymphoma (2006) (0)
- Clinicopathologic characteristics of myeloproliferative neoplasms with JAK2 exon 12 mutation. (2023) (0)
- gene is required for normal murine fetal erythropoiesis α A functional p85 (2013) (0)
- Refractory Anemia With Excess Blasts In Transformation (Acute Myeloid Leukemia with 20-29% Blasts) in Older Adults is Less Aggressive Than Acute Myeloid Leukemia With ≥30% Blasts (2013) (0)
- Clinical and Biological significance of MYC/BCL6 dual gene rearrangements and protein co-expression in de novo diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program (2015) (0)
- Evaluation of Bone Marrowmmorphology in Addition to JAK2 Allele Burden Is Essential for Assessing Disease Status in Recombinant Interferon Alpha-Treated Polycythemia Vera Patients (2016) (0)
- Pathology of the spleen: INTRODUCTION. (2020) (0)
- What’s new in the MDS/MPN overlap syndromes (2023) (0)
- Correlation between presence of clonal rearrangements of immunoglobulin heavy chain genes and B-cell antigen in patients with nodular sclerosis and mixed cellularity Hodgkin's disease (1995) (0)
- A rare case of acute myeloid leukemia with der(1)t(1;19)(p13;p13.1) (2019) (0)
- Myeloid Sarcoma (2019) (0)
- Myeloproliferative neoplasms: changes since the WHO 2016 classification (2023) (0)
- Discordant PET Findings and a High Relapse Rate Characterize Hispanics With Hodgkin's Lymphoma Treated With ABVD. (2021) (0)
- Nuclear coexpression of NF-κB subunit c-Rel and p53 mutants confers significantly poor survival in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: A Report from the International DLBCL Rituximab-CHOP Consortium (2015) (0)
- Illustrated Pathology of the Bone Marrow: Preface (2006) (0)
- Illustrated Pathology of the Bone Marrow: Acute leukemia (2006) (0)
- Loss of Heterozygosity in Bone Marrows of Patients with Iron-Deficiency Anemia. (2006) (0)
- MYC Signatures and Characterization of MYC-Driven Aggressive B-Cell Lymphoma (2015) (0)
- Red cell mass (RCM) determination is essential for proper diagnosis of early stage polycythemia vera (PV) (2012) (0)
- The World Health Organization (WHO) classification recognizes a group of myeloid neoplasms with overlapping features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (2014) (0)
- unclassifiable myelodysplastic/myeloproliferative neoplasms Atypical chronic myeloid leukemia is clinically distinct from (2014) (0)
- ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) as front-line therapy for Hodgkins lymphoma in Hispanic patients: A single center experience from Texas-Mexico Border. (2021) (0)
- Aberrantly sustained PAX5 expression in plasma cell differentiation is a frequent feature in lymphoplasmacytic lymphoma but not marginal zone lymphoma in bone marrow (2013) (0)
- The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion (2018) (0)
- Myeloid Neoplasms in the Liver and Spleen (2020) (0)
- Clinical Implications of TP53 Mutations and p53 Dysfunction in Patients with Myelodysplastic Syndrome (MDS). a Study from the Italian MDS Clinical Network (2017) (0)
- Mesocaval shunt inhibits primary and metastatic hepatoma growth and enhances apoptosis. (1998) (0)
- Illustrated Pathology of the Bone Marrow: Immunosecretory disorders/plasma cell disorders and lymphoplasmacytic lymphoma (2006) (0)
- Retrospective Study of Incidence and Survival for Patients with Hematologic Malignancies Residing at the U.S./Mexico Border (2019) (0)
- MYC Mutation Profiling In 708 De Novo Diffuse Large B-Cell Lymphoma Demonstrates That Genetic Abnormalities In The Coding Sequence and Untranslated Regions Have Different Prognostic and Clinical Significance: A Report From The International DLBCL Rituximab-CHOP Consortium Program (2013) (0)
- international expert panel and primary myelofibrosis: recommendations from an ad hoc diagnostic criteria for polycythemia vera, essential thrombocythemia, Proposals and rationale for revision of the World Health Organization (2009) (0)
- Moving toward more molecular classifications of myelodysplastic syndrome and acute myeloid leukemia (2022) (0)
- Promoter and Exon 1 Hypermethylation of the Tumor Suppressor Gene PRDM1/Blimp-1 indicates Its Pathogenetic Role in EBV-Positive Burkitt Lymphoma, (2011) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Attilio Orazi?
Attilio Orazi is affiliated with the following schools:
